BioUtah Presents at Medical Korea 2026
March 27, 2026
BioUtah president & CEO, Kelvyn Cullimoire, was invited by the Korean Health Industry Development Institute (KHIDI), an agency of the Korean Ministry of Health, to present at the Medical Korea conference on March 19-20, 2026. The topic of Cullimore’s presentation was “Why Utah is a preferred landing place for Korean medical device companies desiring to access the U.S. Market”. Cullimore also participated in a roundtable with key government, economic developement and industry representatives. Medical Korea is a major conference focusing on global business and attracting over 6,000 attendees from 50 countries.
BioUtah signed an MOU with KHIDI in November at the Utah Life Sciences Summit. Also attending was Seth Egan from Co-Diagnostics and Jihyun Kim & Tong-Soo Chung of World Trade Center Utah’s Korean office. The word on Utah as a sifnificant biotech hub is spreading worldwide.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
